The patient and/or family member should notify the healthcare provider immediately if the patient experiences any symptom of fibros ing colonopathy
52) Because of the possible risk of fibrosing colonopathy
with very high doses of enzyme replacement, a ceiling of 75 000 IU of lipase per meal has been recommended by some.
Solvay will also be required to conduct a 10-year observational study to evaluate the incidence of fibrosing colonopathy
in cystic fibrosis patients treated with Creon, and to evaluate the risk of transmission of selected porcine viruses in treated patients, according to the FDA approval letter.
Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
High dose pancreatic enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
This case suggests that multiple etiologic factors, and not simply exposure to pancreatic enzymes, may result in fibrosing colonopathy in adults with cystic fibrosis.
A less well-known complication is fibrosing colonopathy (FCP), characterized histologically by submucosal fibrosis, and clinically by obstructive symptoms.
Cystic fibrosis-associated colitis and fibrosing colonopathy.
High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy.
The incidence of fibrosing colonopathy, associated with high doses of pancreatic enzymes and/or the use of high strength preparations in the early 1990s (7-9), caused many centres treating CF to review the practices of their patients and collaborate to produce national guidelines (4,10,11).
Individuals with CF and their parents were advised against self-adjusting the dose in the 1990s when fibrosing colonopathy was identified by other centres.